🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Organon & Co.

OGN Healthcare
$13.43 +$0.01 (0.07%)
Market Cap: $3.53 B
Gurus Holding
9
Popularity Rank
#668
% of Shares Held
2.87%
Net Activity (Q1 2026)
-$34.99 M

Guru Ownership Trend

Guru Analysis for Organon & Co. (OGN)

Organon & Co. (OGN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $101.37 M.

Top institutional holders include Cliff Asness and HOTCHKIS & WILEY.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $34.99 M net outflow during the quarter.

Recent activity highlights HOTCHKIS & WILEY who opened a new position. Conversely, Steven Cohen reduced exposure by 63.7%.

Key Holders

Top 5 by Value

$20.19 M
$7.53 M
$3.56 M
$2.69 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$8.99 M
Total Buy Value
New Buys 3
Additions 2
-$43.98 M
Total Sell Value
Reductions 4
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
5
Net Buyers
5

FAQs for Organon & Co. (OGN)

Major holders include Cliff Asness ($20.19 M), HOTCHKIS & WILEY ($8.24 M), Joel Greenblatt ($7.53 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 7.55 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $34.99 M, with 5 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 1 fully exited OGN. The total reported sell value was $43.98 M.

Yes, 3 managers opened new positions in OGN, and 2 increased their existing holdings. The total reported buy value was $8.99 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -59.7% 3,450,626 $20.19 M Q1 2026
0.03% New Buy 1,375,960 $8.24 M Q1 2026
0.02% Reduce -52.6% 1,257,055 $7.53 M Q1 2026
0.02% Reduce -34.6% 594,483 $3.56 M Q1 2026
0.01% Add 0.3% 448,874 $2.69 M Q1 2026
0.00% Reduce -63.7% 238,000 $1.43 M Q1 2026
0.01% Add 56.3% 93,576 $560,520 Q1 2026
0.00% New Buy 51,950 $311,181 Q1 2026
0.00% New Buy 37,530 $224,805 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form